Table 3 Comparison between patient with lower EPC counts and those with higher EPC counts
|  | EPC counts < 43 cells per 106 cells (n = 65) | EPC counts ≥43 cells per 106 cells (n = 66) | P-value |
|---|---|---|---|
Flow-mediated dilatation, % | 9.16 ± 5.86 | 6.47 ± 4.33 | 0.009 |
Age, year | 59.38 ± 11.04 | 59.98 ± 11.02 | 0.784 |
Male, n (%) | 29 (44.6) | 33 (50.0) | 0.537 |
Body mass index, kg/m2 | 25.47 ± 3.62 | 25.60 ± 3.40 | 0.858 |
Smoking, n (%) | 16 (24.6) | 12 (18.2) | 0.369 |
Diabetes mellitus, n (%) | 16 (24.6) | 14 (21.2) | 0.643 |
Family history of premature cardiovascular disease, n (%) | 13 (20.0) | 14 (21.2) | 0.864 |
Hypertension, n (%) | 33 (50.8) | 35 (53.0) | 0.796 |
Heart rate, beats/min | 69.04 ± 9.11 | 74.14 ± 10.64 | 0.012 |
Systolic blood pressure, mmHg | 130.16 ± 16.55 | 137.29 ± 15.14 | 0.026 |
Diastolic blood pressure, mmHg | 75.14 ± 8.53 | 74.31 ± 10.81 | 0.669 |
Pulse pressure, mmHg | 54.41 ± 15.08 | 61.92 ± 16.53 | 0.020 |
Serum creatinine, μmol/L | 66.76 ± 13.97 | 65.23 ± 17.01 | 0.627 |
Uric acid, mmol/L | 313.33 ± 86.46 | 337.66 ± 95.91 | 0.188 |
Glucose, mmol/L | 5.40 ± 1.12 | 5.54 ± 1.67 | 0.608 |
HbA1c, % | 6.00 ± 0.55 | 6.29 ± 1.11 | 0.148 |
Total cholesterol, mmol/L | 1.68 ± 0.69 | 1.70 ± 0.85 | 0.882 |
Triglyceride, mmol/L | 4.20 ± 0.90 | 4.25 ± 0.87 | 0.805 |
High-density lipoprotein cholesterol, mmol/L | 1.31 ± 0.35 | 1.35 ± 0.34 | 0.589 |
Low-density lipoprotein cholesterol, mmol/L | 2.44 ± 0.72 | 2.44 ± 0.67 | 0.952 |
Homocysteine, μmol/L | 13.24 ± 4.01 | 13.32 ± 3.99 | 0.439 |
Ejection fraction, % | 65.54 ± 6.27 | 64.82 ± 7.55 | 0.957 |
White blood cell, ×109/L | 6.13 ± 2.34 | 6.75 ± 2.17 | 0.118 |
Neutrophil, × 109/L | 3.51 ± 1.58 | 3.88 ± 1.86 | 0.222 |
Neutrophil-to-lymphocyte ratio | 2.08 ± 1.25 | 1.97 ± 1.12 | 0.057 |
Red blood cell distribution width, % | 12.78 ± 0.76 | 12.96 ± 0.79 | 0.270 |
High-sensitivity C-reactive protein, mg/L | 5.24 ± 11.52 | 6.33 ± 11.62 | 0.802 |